MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

A.I. Advisor

published Earnings

MLTX is expected to report earnings to rise 12.72% to -43 cents per share on November 12

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q3'24

Est.

$-0.44

Q2'24

Missed

by $0.11

Q1'24

Missed

by $0.02

Q4'23

Beat

by $0.11

Q3'23

Beat

by $0.05

The last earnings report on August 07 showed earnings per share of -38 cents, missing the estimate of -27 cents. With 253.70K shares outstanding, the current market capitalization sits at 3.11B.

View a ticker or compare two or three

Compare

MLTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MLTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MLTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Dorfstrasse 29

Phone

+41 415108022

Employees

Web

https://www.moonlaketx.com